LEGN Legend Biotech Corporation ADRs

Legend Biotech is a clinical stage biopharmaceutical company engaged in the discovery and development of novel cell therapies in hematology/oncology, infectious diseases and auto-immune disorders. Legend operates in the USA, mainland China and Ireland. This is an ADR of a company that does not have its stock publicly traded anywhere else in the world.

$47.20  +1.14 (2.48%)
As of 03/27/2023 13:23:02 EST     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  ADRs
Category3:  Mid cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  China
Country of incorporation:  
IPO date:  01/02/2015
Outstanding shares:  154,349,517
Average volume:  600,670
Market cap:   $6,763,595,835
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
Sedol:      BMX9K07

---

Valuation   (See tab for details)

---

PE ratio:   0.00
PB ratio:   0.00
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%